Crispr Therapeutics shares owned by Perigon Wealth Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Perigon Wealth Management
from 13F filings
Historical chart of Perigon Wealth Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Perigon Wealth Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Perigon Wealth Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.2M | 19k | 64.81 |
| 2025-06-30 | $891k | 18k | 48.64 |
| 2025-03-31 | $571k | 17k | 34.03 |
| 2024-12-31 | $675k | 17k | 40.30 |
| 2024-09-30 | $707k | 15k | 46.98 |
| 2024-06-30 | $791k | 15k | 54.01 |
| 2024-03-31 | $1.0M | 15k | 68.16 |
| 2023-12-31 | $934k | 15k | 62.60 |
| 2023-09-30 | $650k | 14k | 45.39 |
| 2023-06-30 | $639k | 11k | 56.14 |
| 2023-03-31 | $524k | 12k | 45.23 |
| 2022-12-31 | $486k | 12k | 40.65 |
| 2022-09-30 | $789k | 12k | 65.36 |
| 2022-06-30 | $722k | 12k | 60.75 |
| 2022-03-31 | $661k | 11k | 62.78 |
| 2021-12-31 | $656k | 8.7k | 75.72 |
| 2021-09-30 | $813k | 7.3k | 111.89 |
| 2021-06-30 | $1.1M | 6.8k | 161.83 |
| 2021-03-31 | $784k | 6.4k | 121.78 |
| 2020-12-31 | $859k | 5.6k | 153.17 |
| 2020-09-30 | $424k | 5.1k | 83.63 |
| 2020-06-30 | $362k | 4.9k | 73.47 |
| 2020-03-31 | $291k | 6.4k | 45.81 |
| 2019-12-31 | $278k | 4.6k | 60.03 |
| 2011-09-30 | $789k | 12k | 65.36 |